EULAR® 2024 Insights
EULAR® 2024 Insights - Interception of the Development of RA by a 1-Year Course of Methotrexate in ACPA-Negative Arthralgia Patients at Increased Risk for RA: 4 Year Results of the TREAT EARLIER Trial
By
EULAR® 2024 Insights
FEATURING
Quirine Dumoulin
By
EULAR® 2024 Insights
FEATURING
Quirine Dumoulin
Comments 0
Login to view comments.
Click here to Login
